Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRISS: RBC Transfusion in Septic Shock
NCT01485315Phase 3Completed
- Sponsor
- Scandinavian Critical Care Trials Group
- Start
- Nov 2011
- Primary completion
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 4
01
Overview
A Phase 3 trial of red blood cells in septic shock, sponsored by Scandinavian Critical Care Trials Group. Started Nov 2011; status: completed.
02
Drugs
red blood cells
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT01485315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01485315.